Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2011 of 6351
-
Could a simple sugar protect bone marrow transplant patients?
Disease control CompletedHigh dose chemotherapy and radiation used as preparative regimens in patients undergoing an allogeneic hematopoietic stem cell transplant (HSCT) disrupts intestinal homeostasis by damaging the intestinal epithelium and altering the intestinal microbiome. The investigators hypothe…
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Breath and blood tests could spot lung cancer early
Diagnosis OngoingDECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between mal…
Sponsor: Boston University • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Can ritalin Jump-Start the brain after a coma?
Disease control OngoingPhase 1 of the STIMPACT trial is an open label,dose-escalation,safety study of intravenous (IV) methylphenidate (MPH) therapy in patients with disorders of consciousness (DoC) caused by severe brain injuries.
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Green tea extract tested to keep prostate cancer in check
Disease control OngoingThis randomized double-blinded Phase II clinical trial will evaluate the bioavailability, safety, effectiveness and validate the mechanism by which a standardized formulation of whole Green Tea Catechin, (Sunphenon® 90D) containing 405 mgs vs. Placebo, administered for 24 months …
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a simple test guide chemo for pancreatic cancer patients?
Knowledge-focused OngoingTo date, there have been no Canadian led neoadjuvant or peri-operative trials, this multicentre design gives the opportunity to build more experience with this strategy across Canada in more institutions. The design of this prospective trial will also test our important hypothese…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New drug cocktail shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis phase II trial studies how well polatuzumab vedotin and combination chemotherapy work in treating patients with previously untreated double, triple hit lymphoma, Double Expressor Lymphoma or High-Grade B Cell Lymphoma. Polatuzumab vedotin is a monoclonal antibody that works …
Phase 2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Video games prescribed: new study tests exergaming to ease cancer fatigue
Symptom relief Recruiting nowThis overall objective of the RCT is to test an intervention to overcome the PA barriers for head and neck cancer (HNC) patients during the first 6 months after their treatment. PAfitME stands for a personalized Physical Activity intervention with fitness graded Motion Exergames.…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Psoriasis breakthrough: lower drug doses may work just as well
Disease control CompletedThe main objective of this study is to investigate whether controlled dose reduction of IL17 or IL23 inhibiting biologics is not inferior compared to usual care in psoriasis patients. Therefore, a pragmatic, multicentre, randomized, controlled, non-inferiority study will be carri…
Phase 4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Navigating hope: can a family coach help foster teens get the mental health care they need?
Symptom relief CompletedThis study will focus on developing and testing a family-based mental health navigator intervention, the Foster Care Family Navigator (FCFN), to evaluate whether the intervention combined with mHealth would be efficacious in improving mental health service initiation and engageme…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New combo tackles tough lung cancer
Disease control OngoingThis is a prospective, open label, interventional trial beginning with a phase 1b safety run-in followed by an expansion cohort.
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Iron pills may give female footballers a performance edge
Disease control CompletedThe aim of the study is to characterize the diet and iron status of young female elite football players and examine the relationship between iron intake, iron status, hemoglobin levels, intestinal health and sports performance. In addition, the effects of low-dose iron supplement…
Sponsor: Norwegian University of Life Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
No-Surgery breast cancer treatment shows promise in early trial
Disease control OngoingThis is a prospective pilot study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) as a treatment for breast cancer in patients who do not get surgery. The study will accrue 15 patients who will be treated to a dose of 40 Gy over the course of 5…
Sponsor: Stony Brook University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug aims to boost red blood cells in MDS patients
Disease control Recruiting nowThe main aim of this study is to learn how safe elritercept is and how well adults with anemia associated with lower-risk MDS tolerate treatment with different doses of elritercept. Other aims are to learn how safe elritercept is by looking at how many participants have MDS that …
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Breathing your way to a sharper mind? new study tests combo therapy for memory loss
Disease control CompletedA recently completed study suggested that processing speed and attention (PS/A) oriented cognitive training (VSOP) produced robust effect on PS/A and working memory, but not in cognitive control or episodic memory, and long-term effects were overall modest. The proposed R01 renew…
Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Timing your meals may ward off diabetes, study finds
Prevention CompletedOne in three American adults have prediabetes, and up to 70% of adults with prediabetes eventually develop type 2 diabetes. With the high cost of treating diabetes, cost-effective approaches are needed to reduce the incidence of diabetes. One new strategy may be to change when pe…
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Quick MRI could outshine ultrasound for liver cancer detection
Diagnosis By invitation onlyThe purpose of this study is to compare the diagnostic value of a reconstructed abbreviated Magnetic Resonance Imaging (MRI) from a full clinical exam, compared to ultrasound (US) for screening of liver cancer. Blood markers will be evaluated to determine their correlation to ima…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for dialysis patients: non-surgical kidney reduction could clear the way for transplant
Disease control Recruiting nowAutosomal dominant polycystic kidney disease (ADPKD) is an inherited cystic disorder characterised by the progressive degeneration of the renal parenchyma into cystic formations, with involvement of other organs to varying degrees and incidence (liver, pancreas and brain). This …
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Zapping the brain to save speech: new hope for aphasia?
Symptom relief CompletedThis is a double-blind, sham-controlled, crossover study in which subjects with the non-fluent/agrammatic and logopenic variants of primary progressive aphasia (naPPA and lvPPA, respectively) will undergo language testing and structural and functional brain imaging before and aft…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedTAK-981 is being tested in combination with pembrolizumab to treat participants who have select advanced or metastatic solid tumors. The study aims are to evaluate the safety, tolerability, and preliminary efficacy of TAK-981 in combination with pembrolizumab. Participants will…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a water pill get ICU patients home faster?
Disease control Recruiting nowThis study evaluates the benefits and harms of goal directed fluid removal with furosemide versus placebo in critical ill adult patients with fluid overload in the intensive care unit. Half of the patients will receive furosemide and the other half placebo. The treatment will con…
Phase 4 • Sponsor: Morten H. Bestle • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC